Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Yes, if he did replicate a cure HIV in monkeys, it

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154867
(Total Views: 527)
Posted On: 11/16/2019 12:19:40 PM
Avatar
Posted By: trding
Re: Bored Lawyer #11055
Yes, if he did replicate a cure HIV in monkeys, it will be accepted and it will make big news.

There was a claim in 2016 that made big news, even Fauci got in talking about it, but it wasn’t replicated when other scientists tried.
Original story,
https://www.sciencemag.org/news/2016/10/antib...-infection

Update on failed replication.
https://www.google.com/amp/s/medicalxpress.co...onkeys.amp

Three teams fail to replicate results of 2016 HIV study that claimed 'cure' in monkeys

Quote:
The work by the team in 2016 involved giving monkeys infected with SIV (the monkey equivalent of HIV) the standard antiviral treatment for HIV—they also administered an antibody to target a protein called a4b7, which prior research had suggested the virus exploits to hide from antibodies. The team reported that nine months after discontinuing treatment, the monkeys showed no signs of resurgence of the virus. It appeared they had found a cure.

News of the possible cure spread quickly through the bioscience community, leading others to attempt to replicate these efforts, but none could. Then, reports emerged that one of the 2016 team members had substituted a different type of SIV virus during the study without telling anyone. Once outed, he explained that he had changed the virus because he thought it was more like the HIV virus in humans. That was enough for Science to publish its editorial of concern.



(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us